Sino Biopharmaceutical | 1177 - Operating Expenses

Stock Price
6.39
Daily Change
0.05 0.79%
Monthly
-1.84%
Yearly
122.65%
Q1 Forecast
6.37

Sino Biopharmaceutical reported CNY12.39B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Jiangsu Hengrui CNY 5.94B 254.97M Sep/2025
Moderna USD 1.28B 232M Sep/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Viatris USD 3.53B 128.7M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025